Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.30 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20873139 | 0.88 | SLC22A6 (0.32) | — | |
| SCHEMBL20873135 | 0.85 | FOLH1 (0.36) | PLA2G2CCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL20873131 | 0.83 | TLR2 (0.40) | — | |
| SCHEMBL20873145 | 0.82 | ADRB2 (0.34) | CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL9515451 | 0.81 | USP2 (0.58) | USP2PLA2G2CCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL28591975 | 0.80 | C3AR1 (0.36) | CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL20873138 | 0.80 | C3AR1 (0.36) | CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL20873149 | 0.80 | USP2 (0.33) | USP2TGFBR1 | |
| Hydrochloric Acid SCHEMBL9129314 | 0.80 | USP2 (0.56) | USP2PLA2G2CCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL23988564 | 0.79 | CYP2C19 (0.34) | USP2CYP1A2CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3466405-B1 | MICROCAPSULES AND COSMETIC COMPRISING THEM | SEIWA KASEI CO LTD (JP) | 2023-06-28 | — | — | EP | disclosed |
| CN-109310618-B | Cosmetic base material and cosmetic containing the same | 株式会社成和化成 | 2021-07-30 | — | — | CN | disclosed |
| US-20200230034-A1 | A COSMETIC SUBSTRATE AND A COSMETIC CONTAINING THE COSMETIC SUBSTRATE | SEIWA KASEI COMPANY, LIMITED (JP) | 2020-07-23 | — | — | US | disclosed |
| EP-3466405-A1 | COSMETIC BASE AND COSMETIC COMPRISING SAME | Seiwa Kasei Company, Limited (JP) | 2019-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200230034-A1 | A COSMETIC SUBSTRATE AND A COSMETIC CONTAINING THE COSMETIC SUBSTRATE | SMS, CUTA, SRM | USP2 2351/4885TGFBR1 3372/4885PLA2G2C 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.